발행물
컨퍼런스
2018년 대한약학회 추계국제학술대회
2018
,
A452, an HDAC6-selective inhibitor, synergistically enhances the anticancer activity of chemotherapeutic agents in colorectal cancer
The 44th Annual Meeting of Korea Cancer Association & 4th International Cancer Conference
Nuclear export of HP1γ is responsible for HPV-mediated p53 degradation in cervical cancer
2018년 대한약학회 춘계국제학술대회
The HDAC6 inhibitor ACY-1215 enhances anticancer activity of oxaliplatin in colorectal cancer cells
2017년 KSMCB 에피유전체학분과 심포지움
2017
ICEM-ACEM 2017
A potent hydroxamic acid-based, small-molecule inhibitor A452 preferentially inhibits HDAC6 activity and induces cytotoxicity toward cancer cells irrespective of p53 status